CellGenix, a manufacturer of GMP-grade raw materials for cell therapy, gene therapy, and tissue-engineered products, has completed the first phase of its headquarters expansion, the company announced on June 21, 2018. The expansion is in response to customer demand, which is expected to increasOriginal Article
You may also like
Pharmaceutical Sales Customer Engagement –...
AstraZeneca’s Polyneuropathy Treatment Recommended...
Designing a Strategic Roadmap for Seamless Product...
AAPS PharmSci 360: LBFs and Tackling Oral Biologic...
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia...
GSK, Cambridge to Partner on R&D for Kidney and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.